Skip to content

    WEST PHARMACEUTICAL SERVICES (WST) financials

    View WST earnings calls

    Price

    Market Cap

    Sector

    Rank

    Performance+33.1% 1Y

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $746.90M
    $748.80M
    $698.00M
    $766.50M
    $804.60M
    +7.7%
    $805.00M
    +7.5%
    $844.90M
    +21.0%
    $872.30M
    +13.8%
    Strengthening
    Operating Profit
    $161.30M
    $159.60M
    $107.00M
    $153.70M
    $167.60M
    +3.9%
    $156.60M
    -1.9%
    $177.10M
    +65.5%
    $179.10M
    +16.5%
    Strengthening
    Net Profit
    $136.00M
    $130.10M
    $89.80M
    $131.80M
    $140.00M
    +2.9%
    $132.10M
    +1.5%
    $138.80M
    +54.6%
    $154.00M
    +16.8%
    Strengthening
    EPS
    $1.87
    $1.24
    $1.82
    $1.94
    +3.7%
    $1.93
    +55.6%
    $2.17
    +19.2%
    Strengthening
    Other Income
    $3.20M
    Interest
    $700.0K
    -$800.0K
    $400.0K
    $100.0K
    $200.0K
    -71.4%
    -$200.0K
    +75.0%
    $1.90M
    +375.0%
    $2.60M
    +2500.0%
    Strengthening
    Depreciation
    Profit before Tax
    $164.50M
    $164.90M
    $110.50M
    $157.00M
    $171.90M
    +4.5%
    $161.50M
    -2.1%
    $180.10M
    +63.0%
    $180.10M
    +14.7%
    Strengthening
    MarginsOPM
    21.6%
    21.3%
    15.3%
    20.1%
    20.8%
    -3.6%
    19.4%
    -8.7%
    21.0%
    +36.7%
    20.5%
    +2.4%
    Strengthening
    Tax
    19.7%
    22.3%
    21.8%
    19.2%
    19.8%
    +0.4%
    20.6%
    -7.6%
    24.8%
    +13.8%
    17.9%
    -7.1%
    Stable
    ReturnsROIC
    2.9%
    2.8%
    1.9%
    2.8%
    3.0%
    +2.9%
    2.8%
    +1.5%
    3.0%
    +54.6%
    3.3%
    +16.8%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$337.40M$439.10M$615.50M$762.60M$894.30M$853.90M$484.60M$791.30M$435.80M
    Short-Term Investments
    Total Current Assets$894.40M$1.06B$1.37B$1.74B$1.92B$1.94B$1.54B$1.98B$1.81B
    Net PP&E$822.00M$909.40M$1.01B$1.13B$1.26B$1.51B$1.69B$1.84B$1.79B
    Goodwill$105.80M$107.80M$111.10M$109.90M$107.30M$108.50M$106.00M$109.90M$108.70M
    Intangibles$20.30M$29.80M$30.50M$23.00M$18.40M$15.10M$10.80M$7.70M$6.40M
    Total Assets$1.98B$2.34B$2.79B$3.31B$3.62B$3.83B$3.64B$4.27B$4.08B
    LiabilitiesTotal Current Liabilities$283.70M$341.60M$503.40M$594.10M$519.00M$671.80M$550.40M$654.90M$640.50M
    Short-Term Debt$100.0K$2.30M$2.30M$44.20M$2.20M$134.00M$0$0$0
    Long-Term Debt$196.00M$255.00M$252.90M$208.80M$206.70M$72.80M$202.60M$202.80M$202.90M
    Long-Term Leases$0$62.40M$60.40M$63.00M$93.00M$84.50M$81.80M$95.60M$88.30M
    Total Liabilities$582.60M$768.20M$939.30M$978.40M$931.90M$948.50M$961.10M$1.09B$1.09B
    EquityCommon Stock & APIC$18.80M$18.80M$18.80M$18.80M$18.80M$18.80M$18.80M$18.80M$18.80M
    Retained Earnings$1.35B$1.55B$1.85B$2.46B$2.99B$3.52B$3.96B$4.37B$4.62B
    Total Equity$1.40B$1.57B$1.85B$2.34B$2.68B$2.88B$2.68B$3.18B$2.99B
    HighlightsNet Cash / (Debt)$141.30M$181.80M$360.30M$509.60M$685.40M$647.10M$282.00M$588.50M$232.90M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$288.60M$367.20M$472.50M$584.00M$724.00M$776.50M$653.40M$754.80M$662.20M
    Cash from Investing-$100.80M-$228.00M-$179.50M-$253.10M-$288.20M-$368.70M-$378.70M-$285.90M-$225.30M
    Cash from Financing-$80.70M-$36.80M-$137.10M-$168.10M-$293.60M-$459.60M-$622.60M-$185.10M-$496.70M
    SummaryCapital Expenditure-$104.70M-$126.40M-$174.40M-$253.40M-$284.60M-$362.00M-$377.00M-$285.90M-$225.30M
    Free Cash Flow$183.90M$240.80M$298.10M$330.60M$439.40M$414.50M$276.40M$468.90M$436.90M
    FCF Margin10.7%13.1%13.9%11.7%15.2%14.1%9.6%15.3%13.1%

    Ratios